Researchers condemn Mater Hospital postponement of cancer drug trials

CANCER researchers have criticised the controversial decision of the Mater Hospital to postpone trials of a new drug on lung cancer patients.

The All-Ireland Co-operative Oncology Research Group otherwise known as ICORG yesterday expressed regret that doctors at the Mater were experiencing difficulties in carrying out clinical research on a new drug to treat lung cancer.

ICORG chief executive Dr Brian Moulton said his members' aim was to enable Irish patients to get early access to the very latest cancer treatments through clinical trials.